BioMarin Pharmaceutical Inc.
↗San Rafael, USA
BioMarin Pharmaceutical is a global biotechnology company dedicated to transforming lives through genetic discovery. The company focuses on developing and commercializing innovative therapies for people with serious and life-threatening rare diseases and medical conditions. Their portfolio includes first-in-class and best-in-class therapies that address the root cause of genetic conditions.
BioMarin is a pioneer in enzyme replacement therapies (ERT) and has recently expanded into gene therapy. The company maintains a significant global footprint with manufacturing facilities and R&D centers focused on high-unmet-need areas such as achondroplasia, hemophilia A, and various mucopolysaccharidosis (MPS) disorders.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$2.4B
Founded:1997
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Investors:Vanguard Group, BlackRock, FMR LLC (Fidelity), State Street Corporation
STOCK
Exchange:NASDAQ
Ticker:BMRN
Market Cap:$15.2B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Enzyme Replacement Therapy, Gene Therapy, Small Molecule, Oligonucleotides
Active Trials:45
Trial Phases:Phase 1: 12 | Phase 2: 15 | Phase 3: 8 | Phase 4: 10
FDA Approvals:8
EMA Approvals:7
CORPORATE STRUCTURE
Subsidiaries:BioMarin International Ltd, BioMarin Manufacturing Ireland Ltd
Key Partnerships:Skyline Therapeutics (Gene therapy collaboration), Deep Genomics (AI-driven drug discovery)
COMPETITION
Position:Leader
Competitors:Sarepta Therapeutics, Ultragenyx Pharmaceutical, Sanofi (Genzyme), Takeda, Roche (Spark Therapeutics)
LEADERSHIP
Key Executives:
Alexander Hardy - CEO
Brian Mueller - CFO
Scientific Founders:Christopher Starr, Grant W. Denison Jr.
Board Members:Richard A. Lerner, Elizabeth McKee Anderson, Willard Dere
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with BioMarin Pharmaceutical Inc.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.